True about leiomyomas effect on estrogen is
**Core Concept**
Leiomyomas, also known as uterine fibroids, are benign tumors of the smooth muscle layer in the uterus. They are known to be influenced by hormonal factors, particularly estrogen, which promotes their growth.
**Why the Correct Answer is Right**
Estrogen promotes the growth of leiomyomas by binding to estrogen receptors, which are present in the tumor cells. This binding activates various signaling pathways that lead to an increase in cell proliferation and tumor growth. The growth of leiomyomas is typically seen during the luteal phase of the menstrual cycle when estrogen levels are high, and this growth is often accompanied by an increase in uterine bleeding. The role of estrogen in leiomyoma growth is further supported by the fact that hormonal therapies, such as GnRH agonists and progestins, can shrink leiomyomas by reducing estrogen levels.
**Why Each Wrong Option is Incorrect**
**Option A:** There is no evidence to suggest that leiomyomas are more aggressive in the presence of low estrogen levels. In fact, the opposite is true, as low estrogen levels can lead to shrinkage of the tumor.
**Option B:** While leiomyomas can cause symptoms such as heavy menstrual bleeding, they are not typically associated with an increased risk of breast cancer. The relationship between leiomyomas and breast cancer is not well established.
**Option C:** Progesterone receptors are present in some leiomyomas, but the primary hormone that promotes their growth is estrogen. Progesterone may play a role in maintaining the growth of leiomyomas, but it is not the primary hormone involved.
**Clinical Pearl / High-Yield Fact**
Leiomyomas are a common cause of abnormal uterine bleeding in women of reproductive age, and their growth is influenced by hormonal factors, particularly estrogen. A key clinical pearl is that hormonal therapies, such as GnRH agonists and progestins, can be effective in shrinking leiomyomas and reducing symptoms.
**Correct Answer: D. Estrogen promotes the growth of leiomyomas by binding to estrogen receptors, leading to an increase in cell proliferation and tumor growth.**